[Asia Economy Reporter Kum Boryeong] Green Cross Cell announced on the 21st that it has acquired a patent related to the 'Activated lymphocytes including cytokine-induced killer cells and a method for manufacturing the same.'



Green Cross Cell stated, "Using the manufacturing method of this invention, we plan to produce an activated lymphocyte composition containing cytokine-induced killer cells with high tumor cell killing ability and proliferation rate, and apply it to anticancer treatment for cancer patients."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing